Construction of a 18F-FDG PET normative database of Japanese healthy elderly subjects and its application to demented and mild cognitive impairment patients

International Journal of Geriatric Psychiatry

Volumn 25, Issue 4, 2010, Pages 352-361

  Iseki, Eizo ^a   Murayama, Norio ^a   Yamamoto, Ryoko ^a   Fujishiro, Hiroshige ^a   Suzuki, Masaru ^a   Kawano, Masato ^b   Miki, Shuya ^b   Sato, Kiyoshi ^a  

^a JUNTENDO TOKYO KOTO GERIATRIC MEDICAL CENTER   (Japan)

^b Nihon Medi Physics   (Japan)

Author keywords

18F FDG PET; Alzheimer's disease; Dementia with Lewy bodies; Frontotemporal lobar degeneration; Mild cognitive impairment; Normative database

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE;

ADULT; AGED; AGING; ARTICLE; BRAIN METABOLISM; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; DATA BASE; DEMENTIA; FEMALE; GERIATRIC PATIENT; GLUCOSE METABOLISM; HUMAN; IMAGE ANALYSIS; JAPANESE; MALE; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGY; POSITRON EMISSION TOMOGRAPHY; RADIODIAGNOSTIC EQUIPMENT AND SUPPLIES;

ADULT; AGED; AGED, 80 AND OVER; COGNITION DISORDERS; DATABASES, FACTUAL; DEMENTIA; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; JAPAN; MALE; MEMORY DISORDERS; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PSYCHIATRIC STATUS RATING SCALES; RADIOPHARMACEUTICALS;

EID: 77949539031     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.2346     Document Type: Article

References (35)

1. Andreason PJ, Zametkin AJ, Guo AC, et al. 1994. Gender-related differences in regional cerebral glucose metabolism in normal volunteers. Psychiatry Res 51: 175-183.
2. Chen W-P, Samuraki M, Yanase D, et al. 2008. Effect of sample size for normal database on diagnostic performance of brain FDG PET for the detection of Alzheimer's disease using automated image analysis. Nucl Med Commun 29: 270-276.
3. 18F]fluoro-2- deoxy-D-glucose/positron-emmision tomography (FDG/PRT). Proc Natl Acad Sci USA 98: 10966-10971.
4. 18F-FDG PET. J Nucl Med 46: 1625-1632.
5. Drzezga A, Grimmer T, Henrikson G, et al. 2008. Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease. Neuroimage 39: 619-633.
6. Franceschi M, Anchisi D, Pelati O, et al. 2005. Glucose metabolism and serotonin receptors in the frontotemporal lobar degeneration. Ann Neurol 57: 216-225.
7. Gur RC, Mozley RH, Mozley PD, et al. 1995. Sex differences in regional glucose metabolism during a resting state. Science 267: 528-531.
8. Herholz K, Salmon E, Perani D, et al. 2002. Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage 17: 302-316.
9. Hodges JR, Patterson K, Oxbury S, Funnell E. 1992. Semantic dementia. Progressive fluent aphasia with temporal lobe atrophy. Brain 115: 1783-1806.
10. 18F-FDG PET in Alzheimer's disease: Validation of anatomic standardization for atrophied brains. J Nucl Med 42: 548-557.
11. Jagust W, Gitcho A, Sun F, et al. 2006. Brain imaging evidence of preclinical Alzheimer's disease in normal aging. Ann Neurol 59: 673-681.
12. Lancaster JL, Woldorff MG, Parsons LM, et al. 2000. Automated Talairach atlas labels for functional brain mapping. Hum Brain Mapp 10: 120-131.
13. McKeith IG, Galasko D, Kosaka K, et al. 1996. Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47: 1113-1124.
14. McKeith IG, Dickson DW, Lowe J, et al. 2005. Diagnosis and management of dementia with Lewy bodies; third report of the DLB consortium. Neurology 65: 1863-1872.
15. McKhann G, Drachman D, Folstein M, et al. 1984. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939-944.
16. Minoshima S, Foster NL, Kuhl DE. 1994. Posterior cingulate cortex in Alzheimer's disease. Lancet 344: 895.
17. Minoshima S, Frey KA, Koeppe RA, et al. 1995. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 36: 1238-1248.
18. Minoshima S, Giordani B, Berent S, et al. 1997. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Am Neurol 42: 85-94.
19. Minoshima S, Foster NL, Sima AA, et al. 2001. Alzheimer' disease versus dementia with Lewy bodies; cerebral metabolic distinction with autopsy confirmation. Ann Neurol 50: 358-365.
20. Miura SA, Schapiro MB, Grady CL, et al. 1990. Effect of gender on glucose utilization rates in healthy humans: a positron emission tomography study. J Neurosci Res 27: 500-504.
21. Mizumura S, Kumita S, Cho K, et al. 2003. Development of quantitative analysis method for stereotactic brain image: assessment of reduced accumulation in extent and severity using anatomical segmentation. Ann Nucl Med 17: 289-295.
22. Mosconi L. 2005. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease: FDG-PET studies in MCI and AD. Eur J Nucl Med Imaging 32: 486-510.
23. 18F-FDG PET database of longitudinally confirmed healthy elderly individuals improves detection of mild cognitive impairment and Alzheimer's disease. J Nucl Med 48: 1129-1134.
24. 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias. J Nucl Med 49: 390-398.
25. Mosimann UP, Mather G, Wesnes KA, et al. 2004. Visual perception in Parkinson disease dementia and dementia with Lewy bodies. Neurology 63: 2091-2096.
26. Murayama N, Iseki E, Yamamoto R, et al. 2007. Utility of the Bender Gestalt Test for differentiation of dementia with Lewy bodies from Alzheimer's disease in patients showing mild to moderate dementia. Dement Geriatr Cogn Disord 23: 258-263.
27. Neary D, Snowden JS, Gustafson L, et al. 1998. Frontotemporal lobar degeneration. A consensus on clinical diagnostic criteria. Neurology 51: 1546-1554.
28. Pardo JV, Lee JT, Sheikh SA, et al. 2007. Where the brain grows old: decline in anterior cingulate and medial prefrontal function with normal aging. Neuroimage 35: 1231-1237.
29. Petersen RC, Doody R, Kurz A, et al. 2001. Current concepts in mild cognitive impairment. Arch Neurol 58: 1985-1992.
30. Peterson RC, Negash S. 2008. Mild cognitive impairment: an overview. CNS Spectr 13: 45-53.
31. Petit-Taboue MC, Landeau B, Desson JF, et al. 1998. Effects of healthy aging on the regional cerebral metabolic rate of glucose assessed with statistical parametric mapping. Neuroimage 7: 176-184.
32. Rosen HJ, Gorno-Tempini ML, Goldman WP, et al. 2002. Patterns of brain atrophy in frontotemporal dementia and semantic dementia. Neurology 58: 198-208.
33. 18F] FDG PET: a clinical validation of statistical parametric mapping. Neuroimage 9: 63-80.
34. Silverman DH, Small GW, Chang CY, et al. 2001. Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome. JAMA 286: 2120-2127.
35. Small GW. 2004. Neuroimaging as a diagnostic tool in dementia with Lewy bodies. Dement Geriatr Cogn Disord 17: 25-31.